AlphAIAlphAI — Financial news for AI agents
fool.com$OSCR

Oscar Health (OSCR) Q3 2026 Earnings Call Transcript

Oscar Health (OSCR) reported Q3 2026 revenue of $5.1B, up 70% YoY, with membership at 2.7M, up 27% YoY. Net income was $167.3M, reversing a prior-year loss. The company raised full-year guidance for revenue, earnings, and adjusted EBITDA. Management highlighted expansion into new markets, product launches, and operational efficiencies.

Original reporting
fool.com
Published Nov 6, 2026, 6:11 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 6:31 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Oscar Health (OSCR) Q3 2026 Earnings Call Transcript — source image
Source · fool.com
Decision brief

The 30-second read

$OSCRBullishHigh
01

Why it matters

The earnings beat and guidance raise suggest continued revenue acceleration and improved profitability.

02

Market read

Earnings beat and raised guidance likely drive short‑term price appreciation.

03

What to watch

possible future regulatory scrutiny on CMS eligibility processes

Relevance 8/10Novelty 8/10Timing: post‑earnings today

Background

Oscar Health reported a strong Q3 2026 performance, expanding membership and raising guidance.

Company-level read

Ticker impact

$OSCRBullishHigh confidence
Context

Q3 2026 earnings released with $5.1B revenue and raised full-year guidance to $19.0-19.3B.

Expected impact

likely upward pressure as market prices in higher revenue and earnings guidance

Evidence & confidence

Revenue and earnings both up year‑over‑year; guidance raised for 2026, suggesting momentum into 2027.

Market effects

Sector

positive signal for health‑tech and ACA marketplace insurers

Regional

potential boost for insurers operating in the expanded 713‑county footprint

Global

limited to U.S. health insurance sector

Counterpoint

What could challenge this read

valuation may already price in growth; risk of higher disenrollments from CMS reviews

Key entities

  • company
    Oscar Health, Inc.

    U.S. health insurance provider listed on NYSE under OSCR

Read at source← All news

Related articles

$OSCRMed

Oscar Health Inc (OSCR) Q3 2026 Earnings Call Highlights: Record Profitability, Raised

Oscar Health (OSCR) reported Q3 2026 earnings with record profitability and raised guidance. Membership declined due to CMS reviews, with more disenrollments expected. Q4 SG&A expenses are projected to rise due to seasonal spending. CEO Mark Bertolini and CFO Richard Blackley discussed market share gains, utilization trends, and CMS program integrity initiatives. The company anticipates stable membership and market growth despite competitive pressures and regulatory uncertainties.

finance.yahoo.com
$HCAMed

Hospital Stocks Soared as Democrats Took Congress

HCA Healthcare (HCA) rose 10.34% to $510.70 on November 4, 2026, following Democratic gains in the U.S. election. Investors anticipate potential policy changes favoring hospitals and Medicaid insurers. Universal Health Services (UHS) and Tenet Healthcare (THC) also saw significant gains. HCA's stock is now valued at $106.68 billion, but analysts warn of potential downside risks if policy changes do not materialize.

247wallst.com